Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY22 results · Apr–Jun 2021
Metropolis Healthcare reported revenue from operations of ₹326.76 crore (up 128.3% from Q1 FY21) and net profit of ₹74.92 crore (up 2502.6% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a consolidated basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 326.76 | 143.13 | +128.3% | 291.73 | +12.0% |
| Other income | 3.76 | 3.15 | +19.3% | 2.07 | +82.2% |
| Total income | 330.53 | 146.28 | +126.0% | 293.80 | +12.5% |
| Profit before tax | 103.08 | 3.51 | 29x | 81.65 | +26.2% |
| Net profit for the period | 74.92 | 2.88 | 26x | 61.32 | +22.2% |
| Attributable to shareholders of the company | 74.89 | 2.90 | 26x | 61.35 | +22.1% |
| EPS, basic (₹) | 14.65 | 0.57 | 26x | 12.05 | +21.6% |
| Net margin (%) | 22.9 | 2.0 | 21.0 |
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 264.10 | 110.78 | +138.4% | 238.36 | +10.8% |
| Other income | 3.28 | 2.37 | +38.0% | 42.08 | −92.2% |
| Total income | 267.38 | 113.15 | +136.3% | 280.44 | −4.7% |
| Profit before tax | 81.73 | 2.07 | 39x | 109.39 | −25.3% |
| Net profit for the period | 59.52 | 2.19 | 27x | 94.30 | −36.9% |
| EPS, basic (₹) | 11.64 | 0.43 | 27x | 18.50 | −37.1% |
| Net margin (%) | 22.5 | 2.0 | 39.6 |
Consolidated
- Filed with BSE
- 07 Aug 2021, 12:15 IST
- Board meeting
- 06 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2021, 12:15 IST
- Board meeting
- 06 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE